Using machine learning, an electronic nose can "smell" early signs of ovarian cancer in the blood. The method is precise and, ...
A new trial is testing whether a specialist medical tampon could help improve the early diagnosis of ovarian cancer. The ...
As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...
Ovarian cancer is often referred to as the “silent killer” because its symptoms can be subtle and easily mistaken for common digestive or menstrual issues. However, for Black women, the silence ...
Divergence in the post-progression interval suggests disparities may concentrate in subsequent-line therapy, surveillance, supportive care, or access to timely interventions outside trial ...
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- The Global Ovarian Cancer Research Consortium awarded its inaugural AI Accelerator Grant to an international research team studying whether artificial ...
OCRA has invested over $122 million in research initiatives, helped secure $3.8 billion in federal funding for research and education programs, and annually supports and engages more than 95,000 ...
Last year, Seattle’s Rivkin Center and Washington state’s Andy Hill Cancer Research Endowment (CARE) Fund joined forces to earmark $1 million in funding for ovarian cancer research. This week, they ...
Many women chalk up bloating or stomach changes to menopause — but experts warn these subtle signs are exactly why ovarian cancer is so often diagnosed late. If the risk climbs sharply after 45, how ...
“That’s the silent killer.” These were the first words this guest opinion column's co-author Marci Houff said when told after her surgery that she had ovarian cancer. Today, as a 16-year survivor of ...
The recipient of the inaugural global research grant will harness AI to uncover insights that could result in more personalized care for women diagnosed with ovarian cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results